Class II · Moderate risk Ongoing
Thyroid
Reason Subpotent Drug
Thyroid
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Labeling: Label Mixup: THYROID, Tablet, 30 mg may have potentially been mislabeled as one of the following drugs: OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1110 mg, NDC 11523726503, Pedigree: AD70655_20, EXP: 5/29/2014; NICOTINE POLACRILEX, LOZENGE, 2 mg, NDC 37205098769, Pedigree: AD73623_7, EXP: 5/30/2014; PYRIDOXINE HCL, Tablet, 50 mg, NDC 51645090901, Pedigree: W002697, EXP: 6/5/2014.
What was recalled
THYROID, Tablet, 30 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00456045801.
- Recalling firm
- Aidapak Services, LLC
- Origin
- WA, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-913-2014
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Thyroid recalls
See all
Class II · Moderate risk Completed
S.P Labs
Reason Failed Stability Specifications
Class II · Moderate risk Completed
S.P.Labs
Reason Failed Stability Specifications
Class II · Moderate risk Terminated
Levothyroxine 25mcg in Ns 1.25ml Syringe
Reason Lack of sterility assurance
Class II · Moderate risk Terminated
Armour Thyroid
Reason CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.